Press releases

13 Jul 2026

DNDi welcomes continued GHIT support for collaboration on dengue and Zika virus drug discovery with Eisai and new partner, the Japan Institute for Health Security 

Press releases

13 Jul 2026

DNDi welcomes GHIT support to advance novel oral drug candidate for leishmaniasis, accelerating progress towards elimination goals

Press releases

8 Jul 2026

Brazil, Malaysia, and Thailand set to start global clinical trial to test promising dengue treatment developed by Serum Institute of India

Stories

30 Jun 2026

Cryptococcal meningitis: Africa’s neglected HIV killer

Publications

30 Jun 2026

2025 DNDi Financial Report

News

29 Jun 2026

Eric Easom, Dr Marcus Lacerda, and Mathieu Lamiaux join the DNDi Board of Directors 

Publications

29 Jun 2026

Advancing global health innovation through Europe-Africa collaboration

Scientific articles

22 Jun 2026

What Is in a Structure? Cell Permeability and Solubility of Series of Macrocycles and Linear Matched Pairs

Journal of Medicinal Chemistry

News

17 Jun 2026

DNDi and Medicines for Malaria Venture (MMV) pool regulatory expertise to accelerate access to lifesaving medicines

Scientific articles

17 Jun 2026

Advancing diagnostics for Chagas disease: key product characteristics and harmonized evaluation strategies – an expert meeting report

BMC Infectious Diseases

Stories

17 Jun 2026

The DNDi-MMV Joint Regulatory Platform: ‘a pioneering programme project for non-profit medical research organizations to speak with one voice’

Press releases

12 Jun 2026

DRC approves the use of acoziborole, a breakthrough one-day oral treatment against sleeping sickness